Progyny, Inc. (PGNY) — Stock Score Summary

Progyny, Inc. (PGNY) has a MoatMap StockRank of 97/100 based on Quality (77/100), Value (44/100), and Momentum (73/100) factor scores. The current signal is STRONG BUY. Progyny is a dominant player in US fertility benefits, but it faces headwinds from corporate cost-cutting and does not align with any of our active macro themes. The business model lacks the global, asset-light compounding runway we seek in this environment.

Progyny, Inc. is a leading fertility and family building benefits management company, providing comprehensive and inclusive fertility solutions to large self-insured employers. The company's unique 'Smart Cycle' model and high success rates offer a differentiated value proposition, driving strong employer adoption and member satisfaction. This innovative approach and clinical expertise create a significant competitive moat in the niche but growing market for fertility benefits.

Key Financial Metrics

Price$25.93
Market Cap$2.0B
P/E (TTM)33.09
P/E (Forward)11.55
Price/Book4.09
Return on Equity14.9%
Return on Invested Capital15.8%
Debt/Equity6.21
Gross Margin24.1%
Operating Margin10.8%
Revenue Growth1.4%
Free Cash Flow$200M

Progyny, Inc. operates in the Healthcare Plans industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Progyny, Inc.’s (PGNY) StockRank?
MoatMap’s StockRank for Progyny, Inc. (PGNY) is 97/100, with a Strong Buy signal. It is a composite of Quality (77), Value (44), and Momentum (73) factor ranks across MoatMap’s 19,000+ stock universe.
Does Progyny, Inc. have an economic moat?
Progyny, Inc. (PGNY) has a Quality factor score of 77/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Progyny, Inc. a buy, hold, or sell?
MoatMap’s current signal for Progyny, Inc. (PGNY) is Strong Buy, based on a StockRank of 97/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Progyny, Inc. in?
Progyny, Inc. (PGNY) operates in the Healthcare sector, specifically the Healthcare Plans industry (United States).